Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026

What the insiders did Net buying

By person

16 insiders · 282 transactions
5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Redmile Group, LLC entity
10% owner
$20.00M (1)
—
+$20.00M
1,954,420
5.02%
$13.94M
—
Baker Bros. Advisors LP entity
10% owner
$2.59M (40)
—
+$2.59M
4,691,392
12.05%
$33.45M
+8.5%
MPM BioVentures 2014, L.P.
10% owner
$2.00M (1)
$4.52M (14)
−$2.52M
8,203,463
21.07%
$58.49M
+90.0%
Mpm Bioventures 2018, L.p.
10% owner
$2.00M (1)
$4.52M (14)
−$2.52M
8,203,463
21.07%
$58.49M
+90.0%
Todd Foley
Director
$2.00M (1)
—
+$2.00M
4,425,784
11.37%
$31.56M
—
Kory James Wentworth
Chief Financial Officer
—
$1.91M (37) scheduled
−$1.91M
117,277
0.3012%
$836.19K
—
Natarajan Sethuraman
President, Research & Develop.
—
$1.90M (21) scheduled
−$1.90M
214,238
0.5502%
$1.53M
+64.1%
Nathan J Dowden
President & COO
—
$1.90M (31) scheduled
−$1.90M
196,060
0.5035%
$1.40M
+315.9%
Dipal Doshi
CEO
—
$1.39M (49)
−$1.39M
517,290
1.33%
$3.69M
+314.5%
Nerissa Kreher
Chief Medical Officer
—
$998.17K (24) scheduled
−$998.17K
40,037
0.1028%
$285.46K
—
5AM Ventures V, L.P. entity
10% owner
$5.00M (1)
$4.07M (13)
+$931.96K
3,877,094
9.96%
$27.64M
+1,071%
Peter S Kim
Director
$641.94K (11)
—
+$641.94K
104,330
0.2679%
$743.87K
+121.8%
Kush Parmar
Director
$5.00M (1)
$4.72M (14)
+$284.85K
2,691,337
6.91%
$19.19M
—
John F Crowley
Director
$48.58K (1)
—
+$48.58K
5,000
0.0128%
$35.65K
—
Bernhardt G Zeiher
Director
$29.32K (1)
—
+$29.32K
5,000
0.0128%
$35.65K
—
Roche Holding Ltd entity
10% owner
—
—
—
2,813,525
7.23%
$20.06M
—